Anti-Human Phosphatidylserine Recombinant Antibody (Bavituximab) (CAT#: TAB-175)

Recombinant monoclonal antibody to phosphatidylserine. Bavituximab is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Immunogen
  • Liposomes containing 70% phosphatidylserine and 30% phosphatidylglycerol.
  • Host Species
  • Mouse
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
  • CAS
  • 648904-28-3
  • Generic Name
  • Bavituximab
  • Biological Half-Life
  • 30 hrs
  • UNII
  • Q16CT95N25
  • MW
  • 145.3 kDa
  • Related Disease
  • Influenza

Product Property

  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Target

  • Alternative Names
  • Bavituximab;648904-28-3;ch3G4;PGN401;Phosphatidylserine;PS;Ptd-L-Ser

Related Resources

  • Biosimilar Overview
Please refer to Bavituximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Bavituximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Bavituximab"

Afuco™ Anti-Phosphatidylserine ADCC Recombinant Antibody (Bavituximab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to phosphatidylserine. Bavituximab is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections.

See other products for "phosphatidylserine"

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-175 Afuco™ Anti-Phosphatidylserine ADCC Recombinant Antibody (Bavituximab), ADCC Enhanced FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody

Recombinant Antibody

CAT Product Name Application Type
MOB-014YJL Mouse Anti-Phosphatidylserine Recombinant Antibody (clone CBP104), AF488 FC, IHC Mouse IgG

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-175. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare